Allograft viability determined by enzyme analysis

Area of Science:

• Nephrology
• Transplantation Immunology
• Biochemistry

Background:

• Assessing kidney graft viability after ischemia is crucial for patient outcomes.
• Enzymatic analysis of venous effluent has limitations in predicting kidney function.
• Postoperative monitoring is essential for managing kidney transplant rejection.

Purpose of the Study:

• To evaluate the utility of serum lactic dehydrogenase (LDH) in assessing kidney allograft function post-ischemia.
• To determine if LDH levels correlate with the response to immunosuppressive therapy during rejection episodes.
• To establish the role of LDH in guiding therapeutic decisions in kidney transplantation.

Main Methods:

• Analysis of enzymatic markers in the venous effluent of ischemically injured kidneys.
• Postoperative serum assays for lactic dehydrogenase (LDH) levels.
• Correlation of LDH levels with clinical outcomes and response to immunosuppression.

Main Results:

• Enzymatic analysis of venous effluent did not accurately predict the kidney's ability to support life.
• Postoperative serum LDH levels are valuable in assessing kidney functional status.
• LDH levels correlate with the response of rejection episodes to immunosuppression.
• A decline in LDH indicates successful treatment, while failure to normalize suggests irreversible rejection.

Conclusions:

• Serum LDH is a valuable biomarker for assessing kidney allograft function and response to immunosuppression.
• LDH monitoring aids in managing kidney transplant rejection but should not be the sole factor in withholding therapy.
• Sustained elevated LDH levels post-transplant can indicate irreversible rejection, guiding prognosis and treatment adjustments.